Snowball logo
logo
6003

Yabao Pharmaceutical Group Co Ltd

600351 SHG
¥6.61+¥0.01  (0.15%)
Estimate
P/E
14.1
EPS
0.47
Beta
0.038
Growth
Revenue, YoY
9.15%
Net income, YoY
5.67%
FCF, YoY
-3.87%
About the company
Ticker
600351
ISIN
CNE000001CM5
Country
China
Sector (GICS)
Healthcare
Yabao Pharmaceutical Group Co., Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, analgesics, psychotropic drugs, women's health products, patches, and general health products. The company was founded in 1978 and is based in Beijing, China.

Frequently asked questions

What sector does Yabao Pharmaceutical Group Co Ltd (600351) operate in?

Yabao Pharmaceutical Group Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Yabao Pharmaceutical Group Co Ltd (600351) current stock price?

As of the latest data, Yabao Pharmaceutical Group Co Ltd stock price is CN¥6.61, with a previous close of CN¥6.60. Yabao Pharmaceutical Group Co Ltd gained CN¥0.01 in the last trading session, representing a 0.15% increase.

What is Yabao Pharmaceutical Group Co Ltd (600351) current market capitalization?

Yabao Pharmaceutical Group Co Ltd market cap is approximately 4.57 billion.

What is Yabao Pharmaceutical Group Co Ltd (600351) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.47.

What is Yabao Pharmaceutical Group Co Ltd (600351) Price-to-Earnings (P/E) ratio?

Yabao Pharmaceutical Group Co Ltd current P/E ratio is 14.06.

Does Yabao Pharmaceutical Group Co Ltd (600351) pay dividends?

No. Yabao Pharmaceutical Group Co Ltd does not pay a dividend.

What is Yabao Pharmaceutical Group Co Ltd (600351) beta (volatility) score?

Yabao Pharmaceutical Group Co Ltd has a beta of 0.038, indicating lower volatility than the overall market.